Introduction Hepatocellular carcinoma (HCC) is the … become a promising drug target in cancer … affects the development and progression of hepatocellular carcinoma by changing … and postoperative sequential treatment in hepatocellular carcinoma. Sci Rep. …

… Classification The histopathological evaluation of HCC was performed according to … 2024 edition)18 organized and developed by Chinese Medical Association Liver … on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 …

… ) for the treatment of advanced hepatocellular carcinoma (HCC) in patients who have developed resistance to … proceed with this trial by both the US FDA and China’s … Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment …

… pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat … treating liver-localized tumors. Efficacy in Orthotopic Hepatocellular Carcinoma (HCC … in development for the treatment of relapsed … Phase 3 trial evaluating Annamycin in …

… and Care Excellence (NICE) to treat certain cases of liver cancer … first-line treatment for adults with advanced or unresectable hepatocellular carcinoma (HCC). This marks … the previous standard-of-care treatment, sorafenib, a tyrosine-kinase inhibitor …

… therapy for patients with unresectable hepatocellular carcinoma (HCC). At the 2025 ESMO … in baseline characteristics across trial populations, showed that nivolumab … were generally manageable following established treatment guidelines. He further noted …

Introduction Hepatocellular carcinoma (HCC) … GALNT14 in HCC development and progression … . Hepatocellular carcinoma: risk factors, diagnosis and treatment. Open … hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Pharmacogenomics. …

… Food and Drug Administration (FDA). The trial will evaluate cadonilimab … for the treatment of advanced hepatocellular carcinoma (HCC) in patients … the impact of pharmaceutical industry regulation and … develops the first-in-class and best-in-class new drugs …

… U.S. Food and Drug Administration (FDA) had issued a … in the intent-to-treat population. ARTACUS continues to … RP2 in hepatocellular carcinoma (HCC) The Phase 2 clinical trial of RP2 … to transform cancer treatment by pioneering the development of novel …

… In DEB-TACE treatment, drug-eluting beads… be effective for treating human HCC. Zhang et … of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis. Small … combination in advanced hepatocellular carcinoma (HCC): phase II trial. Am J …